RxDoctor Payments Data

Laurel Armstrong

Gerontology · Columbus, GANPI 1770078420

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 188 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Among gerontology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,399in general payments, 2019–2025

Across 188 payments — averaging $23.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$790
  • Merck$492
  • E.r. Squibb & Sons, L.L.C.$489
  • AstraZeneca$447
  • Novartis$268
  • Abbott$181
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$4,399100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,399 in reported general payments places this provider in the 90th percentile of 197 gerontology providers in Georgia.

See all gerontology providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban144$148,793
XareltoRivaroxaban47$59,511
Repatha SureclickEvolocumab45$37,972
EntrestoSacubitril/Valsartan24$29,487
JardianceEmpagliflozin25$22,828
BrilintaTicagrelor18$19,581
Ranolazine ErRanolazine100$9,625
Praluent PenAlirocumab14$6,616
Metoprolol Succinate172$2,063
ClopidogrelClopidogrel Bisulfate165$1,756
Rosuvastatin Calcium129$1,668
Atorvastatin Calcium129$1,351
Amiodarone Hcl70$1,225
Carvedilol90$923
Amlodipine Besylate132$715

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$100$148,793144 claims
Johnson & JohnsonXarelto$122$59,51147 claims
NovartisEntresto$268$29,48724 claims
Boehringer IngelheimJardiance$157$22,82825 claims
AstraZenecaBrilinta$447$19,58118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 197 gerontology providers in Georgia.

Other gerontology in Columbus

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →